Can You Take Melatonin Every Night? What We Know About Safety and Long-Term Use
“Can I take melatonin every night?” sounds like a yes-or-no question. It is not. A once-daily dose does not automatically mean open-ended self-treatment; duration, formulation, health conditions and medications still matter.
For Canadian adults, the answer starts with the label and Health Canada guidance. Several months of melatonin has looked reassuring in selected studies, but that does not prove every dose and formulation is safe to use indefinitely.
|
Quick Answer Biogénique Melatonin provides 5 mg per tablet. Its marketed label directs adults to take one tablet once daily at or before bedtime and to consult a health care practitioner for use beyond 4 weeks. Health Canada’s current oral monograph supports melatonin “when needed only” for occasional sleeplessness. Reassuring 6- and 12-month studies largely used 2 mg prolonged-release melatonin, so they do not prove indefinite nightly safety for this 5 mg tablet. |
“Once Daily” Does Not Mean “Take It Forever”
Frequency and duration are different. “Once daily” tells you how often to take the labelled dose, not how many months or years self-treatment should continue.
If you need a sleep aid every night, the sleep problem itself may deserve review. Persistent poor sleep can reflect medical, medication, circadian or behavioural factors that a nightly supplement does not diagnose.
What Health Canada Says About Regular Melatonin Use
Health Canada’s oral melatonin monograph, updated December 19, 2025, supports adult use “when needed only” for occasional sleeplessness and directs use as needed before bedtime. That is not a blanket recommendation for routine nightly wellness use.
Biogénique’s product-specific label directs adults to take one 5 mg tablet once daily at or before bedtime and to consult a health care practitioner for use beyond 4 weeks. That four-week point is the clearest boundary for continued self-use of this product.
What a 6-Month Randomized Trial Found
A randomized trial studied 2 mg prolonged-release melatonin nightly for up to 6 months in adults with primary insomnia; 555 completed the 6-month phase. Benefits were maintained in responding groups, no tolerance signal emerged, and most adverse events were mild with no clinically relevant safety difference versus placebo.
The boundary matters: Biogénique’s current product is a 5 mg tablet and is not labelled as prolonged-release. The trial supports a reassuring medium-term safety signal for its specific 2 mg formulation; it is not a direct six-month trial of Biogénique Melatonin 5 mg.
What 12-Month Data Add - and What They Do Not
An open-label study followed 244 adults using 2 mg prolonged-release melatonin; 96 completed 12 months. Investigators reported no evidence of tolerance, rebound insomnia, withdrawal symptoms or suppression of endogenous melatonin after discontinuation.
Because it was open-label and used a different 2 mg formulation, it cannot establish life-long safety or override the directions of another product.
Why the Long-Term Safety Question Is Still Open
A 2019 systematic review of 37 randomized trials found melatonin generally well tolerated, but most studies lasted four weeks or less and the longest monitoring was 29 weeks. The authors said the shortage of robust long-term randomized data limits conclusions about extended continuous use.
A later review of studies lasting at least six months found few clinically significant adverse events but again emphasized the scarcity of high-quality double-blind long-term trials. “No major signal” is not the same as “all long-term risks are ruled out.”
Does Melatonin Build Tolerance or Cause Withdrawal?
The 6- and 12-month prolonged-release studies did not detect tolerance, rebound insomnia or withdrawal symptoms. That is reassuring, but it is narrower evidence than the absolute claim that melatonin can never create dependence-related problems in any user or formulation.
Do not increase the dose simply because a nightly routine seems less effective. Revisit the sleep problem rather than automatically taking more.
Who Should Be More Careful With Nightly Use
The current label advises consultation before use for several medical conditions and medications, including cardiovascular, immune, liver or kidney disease, seizures, asthma, diabetes, depression, anticoagulants, anticonvulsants, blood-pressure medicines, immunosuppressants, sedative/hypnotic or psychotropic drugs, and steroids.
It also says not to use during pregnancy or breastfeeding, advises against alcohol or other drowsiness-causing products, and warns against driving or using machinery for 5 hours after a dose.
Biogénique Melatonin 5 mg: What the Current Label Actually Supports
Biogénique Melatonin is currently a 30-tablet, 5 mg product under NPN 80063547. Adults are directed to take one tablet once daily at or before bedtime to help re-set the body’s sleep-wake cycle.
That direction is not a promise of indefinite nightly use. If continuous use is going beyond four weeks, the label tells you to involve a health care practitioner.
What Lot PK240514 Quality Testing Can - and Cannot - Tell You
Biogénique’s Quality Control page lists lot PK240514 for Melatonin 5 mg, NPN 80063547. Its COA reports finished-tablet physical, microbial, pathogen and heavy-metal testing, plus 2-minute disintegration against a 30-minute maximum. The tested lot met the listed specifications.
The COA does not display an active-ingredient assay, and its header says 5.50 mg while the current licensed label says 5 mg. This article therefore uses 5 mg from the label/NPN and does not infer potency from the COA.
A Practical “Every Night” Decision Framework
Before turning melatonin into a long-running bedtime habit, use four questions:
-
What problem are you treating? Occasional sleeplessness, jet lag, delayed sleep timing and persistent insomnia are not interchangeable.
-
How long has use continued? With the current Biogénique product, use beyond 4 weeks is a reason to consult a health care practitioner.
-
Has the dose been creeping upward? Do not self-escalate because a nightly dose seems less effective. See the separate dosage guide for the 1 mg vs 3 mg vs 5 mg question.
-
Could another factor be driving the problem? Persistent poor sleep deserves review of sleep schedule, caffeine/alcohol, medications, pain, mood and possible breathing symptoms.
Frequently Asked Questions
Can I take 5 mg of melatonin every night?
Biogénique’s current label permits one 5 mg tablet once daily at or before bedtime, but it also says to consult a health care practitioner for use beyond 4 weeks. That is more useful than a blanket yes/no answer.
Is it safe to take melatonin long term?
Six- to 12-month studies are reassuring in selected adults, particularly with 2 mg prolonged-release melatonin, but indefinite safety is not established.
Does melatonin stop working if you take it every night?
The 6- and 12-month prolonged-release studies did not show evidence of tolerance in their study populations. That does not mean every person, dose or formulation will behave identically.
Do you need to taper melatonin?
The prolonged-release studies discussed here did not detect rebound insomnia or withdrawal symptoms after stopping. If you are using melatonin under professional care, follow that plan.
What if I still need melatonin after a month?
The current Biogénique label says to consult a health care practitioner for use beyond 4 weeks. That review should consider why sleep remains difficult and whether melatonin is still the right tool.
Bottom Line
Medium-term melatonin safety data are reassuring but often overstated. Six-month randomized and 12-month open-label studies of 2 mg prolonged-release melatonin found no clear tolerance, withdrawal or major safety signal, while reviews still note limited rigorous long-term randomized evidence.
For Biogénique Melatonin 5 mg, the marketed label is the source of truth: adults take one tablet once daily at or before bedtime, and use beyond 4 weeks should be discussed with a health care practitioner.
Related Biogénique Resources
Evidence & Compliance Note
This article keeps three evidence layers separate. (1) Biogénique product facts and use directions come from the current marketed label/NPN records for NPN 80063547. (2) Health Canada’s ingredient-level monograph supplies the current regulatory framework for adult oral melatonin, including the “when needed only” framing for occasional sleeplessness. (3) External clinical studies describe specific research formulations, doses, populations and durations. Those study results are not presented as licensed claims for Biogénique Melatonin 5 mg and are not used to override its label.
References
2. Biogénique Melatonin 5 mg. Current marketed product label / NPN 80063547.
7. Biogénique Quality Control. Melatonin 5 mg, NPN 80063547, lot PK240514.
Disclaimer
This article is for general educational purposes and is not medical advice. Follow the product label and consult a qualified health professional if you have a medical condition, take medications, are pregnant or breastfeeding, have persistent sleep problems, or need individualized guidance about dose, duration or discontinuation.